How does the Belgian Financial Services and Markets Authority (FSMA) determine what qualifies as inside information for biotech companies?

When should trade secrets protection be relied upon and what practical steps can be taken to safeguard valuable confidential information?

Interest in nature-based solutions has been hotting up since the UK identified it as a campaign issue in the run

Recent high-profile appointments and developments will bolster the UK's reputation as a forum for litigating complex patent disputes

Reimbursement for patients' app purchases is important next step for rollout of the mHealthBelgium platform

In order to establish obviousness for the purposes of a patent application, it is enough to show that the idea

In applying the insufficiency principles laid down in Regeneron, the High Court highlights some key considerations for patentees looking to

Our regular newsletter looking at Brexit developments in a legal and business context

At 23:00 on 31 December 2020, the Brexit transition period came to end and a new UK data protection regime

The recent decision of Mr Justice Meade in Fisher & Paykel v Flexicare is yet another warning to patent practitioners

Beijing is evolving its cybersecurity approach, after unveiling draft laws that promise to elevate data protection into the domain of